期刊
ANNALS OF INTENSIVE CARE
卷 12, 期 1, 页码 -出版社
SPRINGER
DOI: 10.1186/s13613-022-01004-w
关键词
Acute kidney injury; Citrate; Clotting; CRRT; Continuous renal replacement therapy; Thrombin; Platelets
资金
- Fresenius Medical Care (UK)
This explorative prospective study aimed to investigate the effects of regional citrate anticoagulation (RCA) on thrombin generation, fibrinolysis, and platelet function in critically ill patients receiving continuous renal replacement therapy (CRRT). The results showed that citrate used for anticoagulation during CRRT did not affect thrombin generation, D-dimer, or platelet function. Systemic clotting parameters were consistent with intra-circuit results.
Background: Regional citrate anticoagulation (RCA) is recommended for continuous renal replacement therapy (CRRT). However, filter life varies and premature filter clotting can occur. The aims of this explorative prospective study were to investigate the effects of RCA on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving CRRT, to compare clotting parameters between systemic and intra-circuit blood samples, and to screen participants for coagulation disorders. We recruited critically ill adult patients admitted to a 30-bedded Intensive care unit in a tertiary care hospital who required CRRT with RCA for acute kidney injury (AKI). Patients with pre-existing thrombotic, bleeding tendencies or a CRRT duration less than 48 h were excluded. We measured coagulation and thrombophilia parameters at baseline. Thrombin generation, D-dimer and platelet function were measured pre-CRRT and at 12, 24, 36, 48 and 72 h after commencing CRRT using blood samples taken from the arterial line and the circuit. Results: At baseline, all eleven patients (mean age 62.4 years, 82% male) had Factor VIII and von Willebrand Factor concentrations above reference range and significantly increased peak thrombin generation. During CRRT, there were no significant changes in systemic maximum peak thrombin generation, time to peak thrombin generation, fibrinogen, D-dimer and platelet function analysis. We observed no significant difference between paired samples taken from the patient's arterial line and the circuit. Conclusions: Critically ill patients with AKI requiring CRRT are hypercoagulable. Citrate used for anticoagulation during CRRT does not affect thrombin generation, D-dimer or platelet function. Systemic clotting parameters reflect intra-circuit results.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据